
Gerresheimer AG
Gerresheimer AG (GRRMF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GRRMF · as of Jun 8, 2026
Key Statistics
Explore Gerresheimer AG Data
grrmf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
Competitors & Peers
grrmf competitorsStock Performance
Full HistoryAbout Gerresheimer AG
Gerresheimer AG together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging…
what is gerresheimer ag · grrmf stock overview · gerresheimer ag company profile · who is gerresheimer ag ceo · grrmf OTC · gerresheimer ag headquarters · gerresheimer ag business segments
About Stock Overview & Key Data
Gerresheimer AG (GRRMF) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on OTC since Sep 11, 2009. As of the latest trading session, GRRMF stock price is $32.10, with a market capitalization of $1.1B. The stock has returned -56.50% over the past 12 months and -37.56% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Gerresheimer AG stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Gerresheimer AG reported revenue of $2.0B and net income of $109.7M. For detailed data — including Gerresheimer AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gerresheimer AG (GRRMF) stock price is $32.10. The stock is traded on OTC under the ticker symbol GRRMF. The 52-week range is $19.16 – $73.80.